Audit Trail · Article #458917

Des avancées importantes dans le traitement de la leucémie aiguë

Source article ↗ · Le Devoir · outlet lean: center-left · owner: Le Devoir (independent co-op) (non_profit)

published 2026-06-03T04:00:00 · ingested 2026-06-03T22:34:39.658042

Bias Analysis · B.I.A.S.

CENTER score: 0.20 confidence: 95% vv3

The article primarily focuses on the advancements in leukemia treatment and does not exhibit strong biases. The text is factual and informative, discussing the new approach of sequencing DNA from leukemia cells to better identify mutations.

Trigger phrases: Des avancées importantesOn procède désormais d’abord au séquençage de l’ADN

      computed at 2026-06-04T01:23:30.162543
    

ML Bias Signal · DistilBERT Zero-Shot (v2)

ML scoring pending — backlog worker processes ~50 articles per ingest cycle.

Analysis Tier

Tier: pending

Tier-1 at: —

Tier-2 at: —

AI analyzed: ✓ at 2026-06-04T01:23:30.162543

Geographic Extraction · L.O.C.A.L.

Country: —

Province: QC

Scope: provincial

Fact-Check Claims · V.E.R.I.F.Y. (0)

No claims extracted yet.

Cross-Outlet Cluster · I.N.K.

Des avancées importantes dans le traitement de la leucémie aiguë 1 article across outlets

      clustered at 2026-06-03T22:34:39.797875
    

Governance — C.R.E.E.D.

A+

overall grade

99.5

By Category

Accountability {'events': 4106, 'grade': 'A+', 'score': 98.6}

Fairness {'events': 239436, 'grade': 'A+', 'score': 100.0}

Privacy {'events': 4204, 'grade': 'A+', 'score': 99.7}

Safety {'events': 917, 'grade': 'A+', 'score': 100.0}

Transparency {'events': 3238, 'grade': 'A+', 'score': 99.1}

Ethics audit by C.R.E.E.D. Institute · 251901 events tracked

Raw Audit Trail (1 event)

2026-06-03T22:34:39.658042 ingested

payload

{
  "bias": {
    "band": "center",
    "heuristic_version": "v3",
    "rationale": "triggers: none \u2014 defaulted center",
    "score": 0.0
  },
  "source_id": 592
}

Every signal computed about this article, with timestamps. Source for the transparency promise behind our methodology.